|
CN102711454A
|
|
Methods and compositions for improved delivery, expression or activity of RNA interference agents
|
|
WO2007065016A2
|
|
Methods and compositions to improve activity and reduce toxicity of stents
|
|
US2006034925A1
|
|
Tumor targeting drug-loaded particles
|
|
AU2004228008A1
|
|
Tumor-targeting drug-loaded particles
|
|
AU2004209428A1
|
|
Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
|
|
AU2002330088B2
|
|
Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
|
|
AU5790300A
|
|
Methods and compositions for modulating cell proliferation and cell death
|
|
WO0061141A2
|
|
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
